Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Temple University
With
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Using block randomization, subjects with diabetes were assigned to either the standard or the enhanced education group. The effectiveness of enhanced education was evaluated as measured by foot care behavior score, patient's interpretation of neuropathy scores, and the incidence of diabetic foot complications over a course of 1-year.
Age
21–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female between the ages of 21 and 75 years (inclusive)
Documented type 1 or type 2 diabetes mellitus
Demonstrates peripheral neuropathy (defined as vibration perception threshold (VPT) ≥ 25 volts at the hallux, as quantified by a BioThesiometer, or unable to perceive a 10 gram Semmes-Weinstein monofilament in one four sites on the feet)
Able to walk independently without the use of walking aids (cane, crutches, or walker)
Able to speak and understand English
Able to understand the information in the informed consent form and willing and able to sign the consent form
You may not be if
Amputation of either foot proximal to midfoot
Presence of cutaneous ulceration in the lower extremity
History of or active Charcot neuroarthropathy of either foot
Severe peripheral vascular disease (ie. ischemic rest pain, 2-block claudication or gangrene)
End stage kidney disease requiring hemodialysis, stroke, or widespread malignant disease
Pregnant or nursing
Life expectancy \< 12 months
Not willing or able to make the required follow-up visits
Insufficient (corrected) vision to complete the questionnaires